Intravenous immunoglobulin as an intervention strategy of risk factor modification for prevention of severe infection in heart transplantation

Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):156-8. doi: 10.1111/cei.12552.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agammaglobulinemia / immunology
  • Agammaglobulinemia / therapy
  • Communicable Diseases / immunology*
  • Heart Transplantation / adverse effects*
  • Humans
  • Immunoglobulin G / immunology
  • Immunoglobulin G / therapeutic use
  • Immunoglobulins, Intravenous / immunology*
  • Immunoglobulins, Intravenous / therapeutic use*
  • Pilot Projects
  • Prospective Studies
  • Risk Factors
  • Survival Rate

Substances

  • Immunoglobulin G
  • Immunoglobulins, Intravenous